MedPath

沐邦(北京)医药科技有限公司

Ownership
-
Established
2014-11-02
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Sacubitril Valsartan Sodium Tablets

Product Name
沙库巴曲缬沙坦钠片
Approval Number
国药准字H20253790
Approval Date
Apr 1, 2025
NMPA

Sacubitril Valsartan Sodium Tablets

Product Name
沙库巴曲缬沙坦钠片
Approval Number
国药准字H20253791
Approval Date
Apr 1, 2025
NMPA

Sacubitril Valsartan Sodium Tablets

Product Name
沙库巴曲缬沙坦钠片
Approval Number
国药准字H20253792
Approval Date
Apr 1, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.